Drug sponsors will have to submit essentially every direct-to-consumer television ad to FDA for review prior to dissemination under the agency’s just-released draft guidance. And in a new twist, sponsors will also have to submit information they rely on to support claims made in an ad.
FDA released the draft guidance, “Direct-to Consumer Television Advertisements – FDAAA DTC Television Ad Pre-Dissemination Review Program,” on...